Products for Research Use Only

REH/iRFP stable cell line

CAT: 1049-GTR15423884Size: 1 VialDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1049-GTR15423884Size:1 Vial
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
REH/iRFP cells are derived from the human B-cell acute lymphoblastic leukemia (ALL) cell line REH by stably integration of a constitutive miRFP670 stably expression construct. REH cells are used to study the biology of B-ALL, including signaling pathways, cell proliferation, and apoptosis, as well as test new therapeutic approaches. REH cells can be used to identify suitable antigen targets for CAR-T therapies. Common targets for B-cell malignancies include CD19 and CD22, both of which are expressed on REH cells. REH/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.